• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轻度饮酒有可能抑制非酒精性脂肪性肝病中的肝细胞损伤和肝纤维化。

Light alcohol consumption has the potential to suppress hepatocellular injury and liver fibrosis in non-alcoholic fatty liver disease.

作者信息

Yamada Kazutoshi, Mizukoshi Eishiro, Seike Takuya, Horii Rika, Kitahara Masaaki, Sunagozaka Hajime, Arai Kuniaki, Yamashita Tatsuya, Honda Masao, Kaneko Shuichi

机构信息

Department of Gastroenterology, Graduate School of Medicine, Kanazawa University, Kanazawa, Ishikawa, Japan.

出版信息

PLoS One. 2018 Jan 17;13(1):e0191026. doi: 10.1371/journal.pone.0191026. eCollection 2018.

DOI:10.1371/journal.pone.0191026
PMID:29342182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5771612/
Abstract

BACKGROUND & AIMS: The modest consumption of alcohol has been reported to decrease the incidence of fatty liver or prevalence of steatohepatitis. In this study, we investigated the effect of light alcohol consumption on liver function and gene expression in patients with non-alcoholic fatty liver disease (NAFLD).

METHODS

The study group was formed of 178 patients diagnosed with non-alcoholic fatty liver disease, subclassified into two groups for analysis based on the daily alcohol consumption: non-alcohol group and light alcohol consumer group (≤20 g of ethanol/day). Clinical characteristics, liver histological features, gene expression, comprehensively analyzed using microarrays (BRB-Array tools), and molecular network were evaluated and compared between the two groups.

RESULTS

No significant differences in steatosis or inflammation score were noted among the groups. However, the ballooning and fibrosis scores were significantly lower in the light alcohol consumer group than in the non-alcohol group. Gene expression analysis revealed a marked inhibition of the pathways involved in the immune response in the light alcohol group compared to that in the non-alcohol group.

CONCLUSIONS

Light alcohol consumption might suppress activity of non-alcoholic steatohepatitis by reducing gene expression levels involved in the immune response. This inhibition in gene expression was associated with a lowering of liver fibrosis and hepatocellular injury.

摘要

背景与目的

据报道,适度饮酒可降低脂肪肝的发病率或脂肪性肝炎的患病率。在本研究中,我们调查了轻度饮酒对非酒精性脂肪性肝病(NAFLD)患者肝功能和基因表达的影响。

方法

研究组由178例诊断为非酒精性脂肪性肝病的患者组成,根据每日饮酒量分为两组进行分析:非饮酒组和轻度饮酒组(≤20克乙醇/天)。对两组患者的临床特征、肝脏组织学特征、基因表达(使用微阵列综合分析(BRB-Array工具))和分子网络进行评估和比较。

结果

各组之间在脂肪变性或炎症评分方面未观察到显著差异。然而,轻度饮酒组的气球样变和纤维化评分显著低于非饮酒组。基因表达分析显示,与非饮酒组相比,轻度饮酒组中参与免疫反应的通路受到明显抑制。

结论

轻度饮酒可能通过降低参与免疫反应的基因表达水平来抑制非酒精性脂肪性肝炎的活动。这种基因表达的抑制与肝纤维化和肝细胞损伤的减轻有关。

相似文献

1
Light alcohol consumption has the potential to suppress hepatocellular injury and liver fibrosis in non-alcoholic fatty liver disease.轻度饮酒有可能抑制非酒精性脂肪性肝病中的肝细胞损伤和肝纤维化。
PLoS One. 2018 Jan 17;13(1):e0191026. doi: 10.1371/journal.pone.0191026. eCollection 2018.
2
Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者一生低至中度饮酒与肝纤维化进展程度较低有关。
Scand J Gastroenterol. 2017 Feb;52(2):159-165. doi: 10.1080/00365521.2016.1239759. Epub 2016 Oct 6.
3
Low alcohol consumption increases the risk of impaired glucose tolerance in patients with non-alcoholic fatty liver disease.低酒精摄入量会增加非酒精性脂肪性肝病患者糖耐量受损的风险。
J Gastroenterol. 2016 Nov;51(11):1090-1100. doi: 10.1007/s00535-016-1194-0. Epub 2016 Mar 12.
4
Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD).适量饮酒与非酒精性脂肪性肝病(NAFLD)患者中肝脂肪变性的发生率降低有关。
J Hepatol. 2012 Aug;57(2):384-91. doi: 10.1016/j.jhep.2012.03.024. Epub 2012 Apr 17.
5
Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.氧化型低密度脂蛋白抗体/高密度脂蛋白胆固醇比值与晚期非酒精性脂肪性肝病瘦患者有关。
J Gastroenterol Hepatol. 2016 Sep;31(9):1611-8. doi: 10.1111/jgh.13335.
6
Nonheavy Drinking and Worsening of Noninvasive Fibrosis Markers in Nonalcoholic Fatty Liver Disease: A Cohort Study.非重度饮酒与非酒精性脂肪性肝病患者无创性纤维化标志物恶化的关系:一项队列研究。
Hepatology. 2019 Jan;69(1):64-75. doi: 10.1002/hep.30170. Epub 2018 Dec 26.
7
Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease.非酒精性脂肪性肝病男性适度饮酒与颈动脉斑块或颈动脉狭窄
Atherosclerosis. 2014 Jun;234(2):270-5. doi: 10.1016/j.atherosclerosis.2014.03.001. Epub 2014 Mar 21.
8
Characteristics and diagnosis of NAFLD/NASH.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的特征和诊断。
J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:64-70. doi: 10.1111/jgh.12271.
9
Procoagulant imbalance in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者的促凝失衡。
J Hepatol. 2014 Jul;61(1):148-54. doi: 10.1016/j.jhep.2014.03.013. Epub 2014 Mar 18.
10
Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.在小鼠的高脂肪-高胆固醇-高糖饮食模型中,非酒精性脂肪变性进展为脂肪性肝炎和肝纤维化与促进炎症和肝肿瘤的危险信号的累积平行。
J Transl Med. 2015 Jun 16;13:193. doi: 10.1186/s12967-015-0552-7.

引用本文的文献

1
Mild-moderate alcohol consumption and diabetes are associated with liver fibrosis in patients with biopsy-proven MASLD.在经活检证实为MAFLD的患者中,轻度至中度饮酒和糖尿病与肝纤维化有关。
Front Pharmacol. 2024 Jul 31;15:1437479. doi: 10.3389/fphar.2024.1437479. eCollection 2024.
2
Effect of Low-Dose Alcohol Consumption on Chronic Liver Disease.低剂量饮酒对慢性肝病的影响。
Nutrients. 2024 Feb 23;16(5):613. doi: 10.3390/nu16050613.
3
Exclusive liquor and cocktail consumption is associated with at-risk fibrosis among nonheavy alcohol users with metabolic dysfunction-associated steatotic liver disease.

本文引用的文献

1
Low alcohol consumption increases the risk of impaired glucose tolerance in patients with non-alcoholic fatty liver disease.低酒精摄入量会增加非酒精性脂肪性肝病患者糖耐量受损的风险。
J Gastroenterol. 2016 Nov;51(11):1090-1100. doi: 10.1007/s00535-016-1194-0. Epub 2016 Mar 12.
2
Effect of chronic alcohol consumption on the development and progression of non-alcoholic fatty liver disease (NAFLD).长期饮酒对非酒精性脂肪性肝病(NAFLD)发生发展的影响。
Hepatobiliary Surg Nutr. 2015 Jun;4(3):147-51. doi: 10.3978/j.issn.2304-3881.2014.12.01.
3
Alcohol-induced miR-27a regulates differentiation and M2 macrophage polarization of normal human monocytes.
在患有代谢功能障碍相关脂肪性肝病的非重度饮酒者中,单纯饮用酒类和鸡尾酒与肝纤维化风险增加有关。
Alcohol Clin Exp Res (Hoboken). 2024 Jan;48(1):88-97. doi: 10.1111/acer.15220. Epub 2023 Nov 29.
4
The role of p53 in liver fibrosis.p53在肝纤维化中的作用。
Front Pharmacol. 2022 Oct 24;13:1057829. doi: 10.3389/fphar.2022.1057829. eCollection 2022.
5
Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis.适量饮酒会加速非酒精性脂肪性肝病患者的肝病进展吗?系统评价和叙述性综合。
BMJ Open. 2022 Jan 4;12(1):e049767. doi: 10.1136/bmjopen-2021-049767.
6
Alcohol and Metabolic-associated Fatty Liver Disease.酒精与代谢相关脂肪性肝病
J Clin Transl Hepatol. 2021 Oct 28;9(5):719-730. doi: 10.14218/JCTH.2021.00173. Epub 2021 Jul 19.
7
The Effects of Modest Alcohol Consumption on Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.适度饮酒对非酒精性脂肪性肝病的影响:一项系统评价和荟萃分析。
Front Med (Lausanne). 2021 Aug 27;8:744713. doi: 10.3389/fmed.2021.744713. eCollection 2021.
8
Modest alcohol consumption and risk of advanced liver fibrosis in nonalcoholic fatty liver disease: a systematic review and meta-analysis.非酒精性脂肪性肝病中适度饮酒与晚期肝纤维化风险:一项系统评价和荟萃分析
Ann Gastroenterol. 2021 Jul-Aug;34(4):568-574. doi: 10.20524/aog.2021.0612. Epub 2021 Feb 26.
9
Alcohol consumption leads to loss of healthy life, but the allele may still protect from NASH.饮酒会导致健康寿命的损失,但该等位基因可能仍能预防非酒精性脂肪性肝炎。
Hepatobiliary Surg Nutr. 2021 Jun;10(3):391-393. doi: 10.21037/hbsn-21-49.
10
Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?肝纤维化的病理生理学和治疗选择:能否完全治愈?
Cells. 2021 May 4;10(5):1097. doi: 10.3390/cells10051097.
酒精诱导的miR-27a调节正常人单核细胞的分化和M2巨噬细胞极化。
J Immunol. 2015 Apr 1;194(7):3079-87. doi: 10.4049/jimmunol.1402190. Epub 2015 Feb 25.
4
Gut-liver axis in alcoholic liver disease.酒精性肝病中的肠-肝轴
Gastroenterology. 2015 Jan;148(1):30-6. doi: 10.1053/j.gastro.2014.10.042. Epub 2014 Nov 11.
5
Modest alcohol consumption reduces the incidence of fatty liver in men: a population-based large-scale cohort study.适度饮酒可降低男性脂肪肝的发病率:一项基于人群的大规模队列研究。
J Gastroenterol Hepatol. 2015 Mar;30(3):546-52. doi: 10.1111/jgh.12786.
6
Moderate alcohol induces stress proteins HSF1 and hsp70 and inhibits proinflammatory cytokines resulting in endotoxin tolerance.适量饮酒可诱导应激蛋白 HSF1 和 hsp70,抑制促炎细胞因子,从而产生内毒素耐受。
J Immunol. 2014 Aug 15;193(4):1975-87. doi: 10.4049/jimmunol.1303468. Epub 2014 Jul 14.
7
Alcohol consumption and risk of incident rheumatoid arthritis in women: a prospective study.饮酒与女性新发类风湿关节炎风险的前瞻性研究。
Arthritis Rheumatol. 2014 Aug;66(8):1998-2005. doi: 10.1002/art.38634.
8
The global NAFLD epidemic.全球非酒精性脂肪性肝病流行状况。
Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):686-90. doi: 10.1038/nrgastro.2013.171. Epub 2013 Sep 17.
9
Modest alcohol consumption decreases the risk of non-alcoholic fatty liver disease: a meta-analysis of 43 175 individuals.适度饮酒可降低非酒精性脂肪性肝病的风险:对43175名个体的荟萃分析
Gut. 2014 Mar;63(3):530-2. doi: 10.1136/gutjnl-2013-305718. Epub 2013 Sep 11.
10
Effect of lifetime alcohol consumption on the histological severity of non-alcoholic fatty liver disease.终生饮酒对非酒精性脂肪性肝病组织学严重程度的影响。
Liver Int. 2014 Jan;34(1):129-35. doi: 10.1111/liv.12230. Epub 2013 Jun 28.